RB1 and hepatocellular carcinoma: Through the comprehensive analysis of the epigenome, transcriptome, and proteome of drug-resistant and wild-type cells, and verification at the cellular level and in clinical samples, we found that the mechanism of apatinib resistance in HCC depends on changes in RB1 signaling.